english.prescrire.org > Spotlight > 100 most recent

Spotlight

Every month, the subjects in Prescrire’s Spotlight.

100 most recent :  1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90

When to take a safety signal into account: Prescrire's experience

Defending the right to compensation for the victims of drug-induced harms

Patient characteristics

Nirsevimab (Beyfortus°) to prevent RSV infection in infants

Negative post-marketing trials: often ignored

Ustekinumab (Stelara°): no live vaccines before 6 months of age for infants who have been exposed in utero

Zonisamide: as dangerous as topiramate during pregnancy?

France's health technology assessment body: pushed to lower the bar!

Drugs to avoid: an analysis of Australia’s pharmaceuticals market

Proposed multi-stakeholder platform to improve clinical trials in the European Union

1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90